Exceeding sales targets by 400%... this could be an interesting buy after these initial sales in 2019 are confirmed.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025